ND
Nicholas C. Denko

Elite Scholar

433
Works
13,173
Citations
48
H-Index
Search Authors
Author Statistics
External Links
OpenAlex Profile ORCID Profile

Nicholas C. Denko

Also known as: Denko Nicholas, N C Denko, N Denko, N. C. Denko, N. DENKO

433

Total Works

13,173

Citations

48

H-Index

84

i10-Index

Citation & Works Trend by Year
37 years active
Top Research Topics
Gut microbiota and health (204) Cancer, Hypoxia, and Metabolism (184) Cancer Immunotherapy and Biomarkers (171) Cutaneous Melanoma Detection and Management (57) Genomics and Phylogenetic Studies (41)
Recent Publications
15 shown
Year Publication Title Citations Action
2026 A Phase 1 Trial Investigating the Addition of Papaverine to Stereotactic Body Radiotherapy (SBRT) for Hypoxic Radiosensitization of Lung Tumors International Journal of Radiation Oncology*Biology*Physics 0
2026 A Dose Escalation Study of Papaverine As a Selective Hypoxic Radiosensitizer for Lung Stereotactic Body Radiation Therapy (SBRT) In the Treatment of Early-Stage Non-Small Cell Lung Cancer (NSCLC) and Other Malignancies International Journal of Radiation Oncology*Biology*Physics 0
2026 Stearoyl-CoA desaturases regulate intestinal stem and progenitor cell metabolism and function in response to nutrient abundance Cell Reports 0
2026 Mitochondrial Oxygen Consumption Drives Lung Tumor Hypoxia and Resistance to Therapy via Copy Number Alteration in Mitochondrial Electron Transport Subunit NDUFB5 bioRxiv (Cold Spring Harbor Laboratory) 0
2026 Abstract 557: TRAP1 represents a mitochondrial target and biomarker of dedifferentiated liposarcoma. Cancer Research 0
2026 Abstract 63: Intratumoral Candida albicans associates with hypoxia and poor outcomes in non small cell lung cancer (NSCLC). Cancer Research 0
2026 Decreasing hypoxia with mitochondrial inhibition in locally advanced rectal cancer: Phase 1 trial of papaverine in combination with radiation (DINOMITE). Journal of Clinical Oncology 0
2025 Supplementary Table S7 from Epigenetic Modulation, Intratumoral Microbiome, and Immunity in Early-Onset Colorectal Cancer 0
2025 Figure 3 from Epigenetic Modulation, Intratumoral Microbiome, and Immunity in Early-Onset Colorectal Cancer 0
2025 Supplementary Figure S3 from Epigenetic Modulation, Intratumoral Microbiome, and Immunity in Early-Onset Colorectal Cancer 0
2025 Supplementary Table S6 from Epigenetic Modulation, Intratumoral Microbiome, and Immunity in Early-Onset Colorectal Cancer 0
2025 Supplementary Table S5 from Epigenetic Modulation, Intratumoral Microbiome, and Immunity in Early-Onset Colorectal Cancer 0
2025 Supplementary Figure S2 from Epigenetic Modulation, Intratumoral Microbiome, and Immunity in Early-Onset Colorectal Cancer 0
2025 Supplementary Table S1 from Epigenetic Modulation, Intratumoral Microbiome, and Immunity in Early-Onset Colorectal Cancer 0
2025 Supplementary Table S9 from Epigenetic Modulation, Intratumoral Microbiome, and Immunity in Early-Onset Colorectal Cancer 0

Data source: OpenAlex API